His main research concerns Immunology, Virology, Serology, Antibody and Internal medicine. His Immunology research incorporates themes from Cervical cancer, Cervical intraepithelial neoplasia and HPV infection. When carried out as part of a general Virology research project, his work on Virus and JC virus is frequently linked to work in Clindamycin and Ampicillin, therefore connecting diverse disciplines of study.
Raphael P. Viscidi combines subjects such as Antitoxin, In vitro and Colitis with his study of Antibody. Internal medicine is often connected to Oncology in his work. His Odds ratio research is multidisciplinary, incorporating perspectives in Sex organ and Case-control study.
Raphael P. Viscidi mainly investigates Immunology, Virology, Antibody, Virus and Serology. The concepts of his Immunology study are interwoven with issues in Internal medicine and HPV infection. His Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
The various areas that Raphael P. Viscidi examines in his Virology study include BK virus, Epitope, Antigen, Immunoassay and Molecular biology. His Antibody study combines topics in areas such as Papillomaviridae and Capsid. Raphael P. Viscidi interconnects Case-control study and Risk factor in the investigation of issues within Odds ratio.
Raphael P. Viscidi focuses on Immunology, Virology, Antibody, Internal medicine and Antigen. His work is dedicated to discovering how Immunology, BK virus are connected with Viremia and other disciplines. His Virology research is multidisciplinary, relying on both Acquired immunodeficiency syndrome and Immune system.
His biological study spans a wide range of topics, including Nested case-control study, Disease, HPV infection and Capsid. His study brings together the fields of Oncology and Internal medicine. Raphael P. Viscidi has researched Antigen in several fields, including Cyst, Prostatic acid phosphatase, Cancer research and Immunotherapy.
His primary scientific interests are in Immunology, Antibody, Virology, Antigen and Human papillomavirus. His research in Immunology intersects with topics in Vaginal atrophy and Disease. He combines subjects such as Gastroenterology, Internal medicine, Incidence and HPV infection with his study of Antibody.
The study incorporates disciplines such as Oncology, Hpv types, Genotype, Sex organ and Seroconversion in addition to HPV infection. His Antigen research integrates issues from Carcinogenesis, Chronic infection, Immune system and Toxoplasmosis. His research integrates issues of Family medicine, Mass screening, Alternative medicine, Gynecology and Cervical cancer screening in his study of Human papillomavirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Case-control study of human papillomavirus and oropharyngeal cancer.
Aimee R. Kreimer;Raphael Viscidi;Michael Pawlita;Carole Fakhry.
The New England Journal of Medicine (2007)
Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
Maura L. Gillison;Gypsyamber D'Souza;William Westra;Elizabeth Sugar.
Journal of the National Cancer Institute (2008)
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska.
Journal of the National Cancer Institute (2003)
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations
Raphael Viscidi;Raphael Viscidi;Raphael Viscidi;Sandra Willey;Sandra Willey;Sandra Willey;John G. Bartlett;John G. Bartlett;John G. Bartlett.
Gastroenterology (1981)
ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PRESENTATION OF ANTIGENS
Tzyy-Choou Wu;F. G. Guarnieri;K. F. Staveley-O'carroll;R. P. Viscidi.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1
Raphael P. Viscidi;Kumudini Mayur;Howard M. Lederman;Alan D. Frankel.
Science (1989)
Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy
Rebecca M. Brotman;Michelle D. Shardell;Pawel Gajer;Doug Fadrosh.
Menopause (2014)
Epidemiologic and Microbiologic Correlates of Chlamydia Trachomatis Infection in Sexual Partnerships
T.C. Quinn;C. Gaydos;M. Shepherd;L. Bobo.
JAMA (1996)
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
Mark H Einstein;John T Schiller;Raphael P Viscidi;Howard D Strickler.
Lancet Infectious Diseases (2009)
Serum Antibody Response to Toxins A and B of Clostridium difficile
R. Viscidi;B. E. Laughon;R. Yolken;P. Bo-Linn.
The Journal of Infectious Diseases (1983)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Johns Hopkins University
University of South Florida
National Institutes of Health
National Institutes of Health
Northwestern University
Albert Einstein College of Medicine
International Agency For Research On Cancer
George Washington University
Johns Hopkins University
Royal Institute of Technology
University of Tokyo
University of Porto
Federal University of Toulouse Midi-Pyrénées
The University of Texas Southwestern Medical Center
University of Eastern Finland
Cincinnati Children's Hospital Medical Center
Weizmann Institute of Science
University of Arizona
Uniformed Services University of the Health Sciences
Swarthmore College
Utrecht University
Children's Hospital of Philadelphia
University of Zurich
University of Bergen
University of Oregon